Related Experiment Video
Updated: May 5, 2026

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
Outcomes after implantable left ventricular assist device replacement procedures.
Matthew A Schechter1, Mani A Daneshmand, Chetan B Patel
1From the *Department of Surgery, Duke University Medical Center, Durham, North Carolina; and †Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Left ventricular assist device (LVAD) replacement surgery is necessary for device failure, thrombosis, or infection. Outcomes after LVAD replacement are worse than primary implants, especially for emergent procedures.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Medical Device Engineering
Background:
- Continuous flow left ventricular assist devices (LVADs) are increasingly used for advanced heart failure.
- Device longevity is a concern, necessitating potential LVAD replacement over time.
- Outcomes following LVAD replacement surgery are not well-established compared to primary LVAD implantation.
Purpose of the Study:
- To compare outcomes between patients undergoing replacement LVAD surgery and those receiving primary LVAD implants.
- To identify major indications for LVAD replacement procedures.
- To analyze survival rates and postoperative complications in LVAD replacement patients.
Main Methods:
- Retrospective analysis of 342 LVAD procedures from 2003-2012, with 30 patients undergoing 35 replacement procedures.
- Propensity matching of replacement patients with primary implant patients based on preoperative characteristics.
- Comparison of 30-day and 1-year survival, transfusion needs, organ dysfunction, hospitalization length, infection, and stroke rates.
Main Results:
- Major indications for LVAD replacement were mechanical/electrical failure (57%), hemolysis/thrombosis (29%), and infection (14%).
- Thirty-day survival was 90% and 1-year survival was 48% after LVAD replacement.
- Survival outcomes were significantly worse for LVAD replacement patients compared to matched primary implant patients (p=0.03).
- Postoperative complications such as transfusion, right ventricular dysfunction, renal dysfunction, infection, and stroke were similar between groups.
- Emergent replacement procedures were associated with higher mortality.
Conclusions:
- LVAD replacement is associated with worse survival outcomes compared to primary LVAD implantation.
- While some complications are similar, emergent replacement carries increased mortality risk.
- Strategies like earlier replacement timing, extracorporeal device stabilization, and non-sternotomy approaches warrant further investigation to improve LVAD replacement outcomes.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management

